| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.42 | 1e-30 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.42 | 1e-30 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-18 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.42 | 2e-11 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-11 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.42 | 3e-09 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |